Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Effects Of Dose, PH, And Osmolarity On Nasal Absorption Of Secretin In Rats.
T. Ohwaki, H. Ando, S. Watanabe, Yasuo Miyake
Published 1985 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
The effects of dose, pH, and osmolarity on the nasal absorption of a secretin solution were studied in rats. The nasal absorption of secretin was determined by measuring the increased secretion of pancreatic juice, and this was compared with the same response on intravenous administration. The relative bioavailability of secretin on intranasal administration compared with intravenous administration, as estimated from the pharmacological response, was approximately one-tenth. It was enhanced in acid solution and reached a maximum in a 0.462 M sodium chloride solution.
This paper references
PROGRESSIVE FIBROSIS OF THE QUADRICEPS MUSCLES.
F. P. Saunders (1965)
Influence of osmotic pressure and viscosity on intestinal drug absorption. II Quinine concentration profile in plasma after oral administration of various quinine solutions to rats.
Y. Sakiya (1981)
Nasal absorption of propranolol from different dosage forms by rats and dogs.
A. Hussain (1980)
Inhibition by secretin of the gastric acid responses to meals and to pentagastrin in duodenal ulcer patients
S. Konturek (1973)
Treatment of duodenal ulcer with secretin: a speculative proposal.
M. Grossman (1966)
The effects of some sweetening agents and osmotic pressure on the intestinal absorption of sulfafurazole in the rat
M. Marvola (1979)
The bioassay of secretin in the rat.
S. Tachibana (1971)
This paper is referenced by
Biopharmaceutical Aspects on the Intranasal Administration of Peptides
A. Harris (1986)
Toxicological Implications of Nasal Formulations
M. Quadir (1999)
Peptide and protein drugs: II. Non-parenteral routes of delivery
X. Zhou (1991)
Just How Prevalent are Peptide Therapeutic Products? A Critical Review.
Y. Zhang (2020)
Nasal-nanotechnology: revolution for efficient therapeutics delivery
A. Kumar (2016)
Microspheres as a nasal delivery system for peptide drugs
P. Edman (1992)
Loss of the V-ATPase B1 Subunit Isoform Expressed in Non-Neuronal Cells of the Mouse Olfactory Epithelium Impairs Olfactory Function
T. G. Paunescu (2012)
Permeability issues in nasal drug delivery.
P. Arora (2002)
Prodrugs in nasal drug delivery
G. Tirucherai (2001)
Vergleichende Permeabilitäts- und Penetrationsstudien in vitro an Schweinekornea und Rindernasenmukosa sowie biophysikalische Untersuchungen an potentiellen Formulierungen (Mikroemulsionen)
Telse Erika Richter (2004)
NASAL VACCINE: A NOVEL APPROACH IN NASAL DRUG DELIVERY SYSTEM
S. Raut (2015)
Intranasal drug delivery system- A glimpse to become maestro
S. Upadhyay (2011)
Inhalation Drug Therapy: Emerging Trends in Nasal and Pulmonary Drug Delivery
M. Lalan (2019)
Rectal Absorption of E‐2078 (Dynorphin Analogue Peptide) in Rats
N. Murahashi (1989)
Bioavailability of intranasal drug delivery system
S. B. Bhise (2008)
Nasal absorption in the rat. I: A method to demonstrate the histological effects of nasal formulations
Susan G. Chandler (1991)
Effect of bile salts on nasal permeability in vitro.
S. Hersey (1987)
Nasal delivery of recombinant human growth hormone with pheroid technology
J. D. Steyn (2006)
Nasal administration of desmopressin by spray and drops
A. Harris (1987)
Nose-to-brain delivery of antipsychotics using nanotechnology: a review
M. S. Tan (2020)
Effect of absorption promoters on the nasal absorption of drugs with various molecular weights
A. Yamamoto (1993)
Effects of formulation variables on nasal epithelial cell integrity: Biochemical evaluations
Chetan P. Pujara (1995)
Delivery Systems for Peptide Drugs
S. S. Davis (1986)
Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts.
P. Tengamnuay (2000)
Intranasal administration of peptides: nasal deposition, biological response, and absorption of desmopressin.
A. Harris (1986)
Techniques of Intranasal Steroid Use
M. Benninger (2004)
A REVIEW ON NASAL DRUG DELIVERY SYSTEM FOR BRAIN TARGETING WITH RECENT ADVANCEMENT
Rohit Sharma (2016)
The effect of molecular size on the nasal absorption of water‐soluble compounds in the albino rat
A. Fisher (1987)
Nasal Drug Delivery System-Factors Affecting and Applications
K. Jadhav (2007)
Model of Disposition of Drugs Administered into the Human Nasal Cavity
I. Gonda (2004)
Prospects for Intranasal Delivery of Neuropeptides to the Brain
K. Shevchenko (2019)
INTRANASAL DRUG DELIVERY SYSTEM : A REVIEW
Pratikkumar A. Mistri (2012)See more